Real-time enrollment status for this idh1-mutated malignancies clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:04 PM UTC
| NCT Number | NCT07006688 |
| Recruiting Status | Recruiting |
| Condition | IDH1-Mutated Malignancies |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Servier Bio-Innovation LLC |
| Last Updated on CT.gov | May 12, 2026 (May 12, 2026) |
As of July 13, 2026: Clinical trial NCT07006688 is currently recruiting participants. This clinical trial study for idh1-mutated malignancies is actively seeking new participants at 2 locations across the United States. The study is sponsored by Servier Bio-Innovation LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07006688 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07006688 was last updated May 12, 2026 (May 12, 2026). HelloStudys verifies this status automatically.